Is Glaxosmithkline Caribbean Ltd on an FDA import alert?

No listing for Glaxosmithkline Caribbean Ltd appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Jamaica page.

Has FDA refused shipments from Glaxosmithkline Caribbean Ltd?

Yes. FDA refused 2 shipment lines from Glaxosmithkline Caribbean Ltd on March 30, 2017. The most recent, on March 30, 2017, was cereal preparations not elsewhere mentioned, n.e.c., charged as NUTRIT LBL (nutrition information missing from label).

Why did FDA refuse Glaxosmithkline Caribbean Ltd's shipments?

The most frequent charge is NUTRIT LBL (nutrition information missing from label, 2 lines).

What is Glaxosmithkline Caribbean Ltd's FEI number?

Glaxosmithkline Caribbean Ltd's FDA Establishment Identifier (FEI) is 3003947605.

Glaxosmithkline Caribbean Ltd

FDA import alert and refusal historyKingston, JamaicaFEI 3003947605

Watch this supplier

As of October 26, 2026, Glaxosmithkline Caribbean Ltd is not on any FDA import alert in SupplierRadar's records; FDA refused 2 of its shipment lines on March 30, 2017, most often for nutrition information missing from label (NUTRIT LBL).

Data from FDA public records, last checked October 26, 2026. Request a correction

Current status

Import alerts: Not listed
Last import refusal: Mar 30, 2017Cereal preparations not elsewhere mentioned, n.e.c. · NUTRIT LBL
Last warning letter: None found
Last inspection: None on record

Every FDA record for Glaxosmithkline Caribbean Ltd

2 records, newest first. Each line links to the FDA page it came from.

2017

Mar 30, 2017Import refusal
Refused, 2 lines in one entry: Cereal preparations not elsewhere mentioned, n.e.c.NUTRIT LBLEntry K51-0087555-5Show 2 linesHide lines
- Refused, Cereal preparations not elsewhere mentioned, n.e.c.NUTRIT LBLEntry K51-0087555-5Source
- Refused, Cereal preparations not elsewhere mentioned, n.e.c.NUTRIT LBLEntry K51-0087555-5Source
Source

Refusal charges, in plain English

NUTRIT LBL2 refused lines
Nutrition information missing from label
The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

Questions about Glaxosmithkline Caribbean Ltd

Is Glaxosmithkline Caribbean Ltd on an FDA import alert?: No listing for Glaxosmithkline Caribbean Ltd appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Jamaica page.
Has FDA refused shipments from Glaxosmithkline Caribbean Ltd?: Yes. FDA refused 2 shipment lines from Glaxosmithkline Caribbean Ltd on March 30, 2017. The most recent, on March 30, 2017, was cereal preparations not elsewhere mentioned, n.e.c., charged as NUTRIT LBL (nutrition information missing from label).
Why did FDA refuse Glaxosmithkline Caribbean Ltd's shipments?: The most frequent charge is NUTRIT LBL (nutrition information missing from label, 2 lines).
What is Glaxosmithkline Caribbean Ltd's FEI number?: Glaxosmithkline Caribbean Ltd's FDA Establishment Identifier (FEI) is 3003947605.

Watch this supplier

Get an email when FDA publishes anything new on Glaxosmithkline Caribbean Ltd.

An email with the FDA source, and a dated PDF for your FSVP file. First supplier free.

Watch this supplier

Related records

Guides

Get this record's changes by email

Watch this supplier

Buying from Glaxosmithkline Caribbean Ltd?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.